Belgium vs Russian Federation: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Belgium
94.0%
in 2024
Russian Federation
94.0%
in 2024
Belgium rank
34th
Russian Federation rank
34th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Belgium
- Russian Federation
How they compare
Belgium currently reports 94.0% against 94.0% in Russian Federation, a difference of 0.0%.
The two have swapped places 1 time across 9 shared years of data; in 2016 it was Belgium ahead.
Belgium ranks 34th and Russian Federation ranks 34th of 146 countries.
Belgium has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belgium | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 94.0% | 67.8% | 26.2% | Belgium |
| 2020s | 94.0% | 91.0% | 3.0% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Belgium or Russian Federation?
- Belgium, at 94.0% against 94.0% in Russian Federation as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Belgium and Russian Federation?
- 0.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Russian Federation?
- 9 years are reported by both, from 2016 to 2024.
- How do Belgium and Russian Federation rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Belgium ranks 34th and Russian Federation ranks 34th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.